Distinct Changes in Serum Fibroblast Growth Factor 21 Levels in Different Subtypes of Diabetes - Concepedia

Concepedia

Publication | Closed Access

Distinct Changes in Serum Fibroblast Growth Factor 21 Levels in Different Subtypes of Diabetes

101

Citations

20

References

2011

Year

Yang Xiao, Aimin Xu, Lawrence Siu‐Chun Law, Cheng Chen, Hui Li, Xia Li, Lin Yang, Shiping Liu, Zhiguang Zhou, Karen S.L. Lam

The Journal of Clinical Endocrinology & Metabolism

Abstract

Serum FGF21 level is increased in type 2 diabetes but decreased in type 1 diabetes and LADA. In autoimmune diabetes, the reduction in circulating FGF21 is closely associated with markers of pancreatic β-cell autoimmunity.

References

	Year	Citations
Diagnosis and Classification of Diabetes Mellitus Diabetes Care	2010	14K
Diagnosis and Classification of Diabetes Mellitus Diabetes Care Diabetes ManagementDiabetesDiagnosisPathologyDiabetes Mellitus	2007	1.1K
Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans Xinmei Zhang, Dennis C.Y. Yeung, Michal Karpíšek, Diabetes	2008	883
Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State Ffolliott M. Fisher, Patricia C. Chui, Patrick J. Antonellis, Diabetes	2010	812
Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse Klementina Fon Tacer, Angie L. Bookout, Xunshan Ding, Molecular Endocrinology Cell ProliferationCell GrowthMammary Gland DevelopmentMost FgfsSignaling Pathway	2010	674
Fibroblast Growth Factor-21 Improves Pancreatic β-Cell Function and Survival by Activation of Extracellular Signal–Regulated Kinase 1/2 and Akt Signaling Pathways Wolf Wente, Alexander M. Efanov, Martin Brenner, Diabetes Cell ProliferationInsulin SignalingTumor BiologyMetabolic SyndromePancreatic Cancer	2006	489
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride Huating Li, Qichen Fang, Fei Gao, Journal of Hepatology PathologyFatty Liver DiseaseObesityMetabolic SyndromeBody Composition	2010	388
Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance Alberto O. Chávez, Marjorie Molina‐Carrión, Muhammad Abdul-Ghani, Diabetes Care	2009	388
Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor‐21 in patients with type 2 diabetes and obesity Miloš Mráz, Markéta Bártlová, Z Lacinová, Clinical Endocrinology	2008	279
Detection of GAD65 Antibodies in Diabetes and Other Autoimmune Diseases Using a Simple Radioligand Assay Jacob Petersen, Kim R Hejnaæs, Alister J. Moody, Diabetes	1994	258

Page 1